drugset / Trial / NCT00130156
Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate the efficacy and safety of Bunazosin with Valsartin compared to Doxazosin with Valsartin for patients with mild to moderate essential hypertension accompanied by metabolic syndrome.
Timeline
- Start
- 2005-10
- Primary completion
- 2008-09
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bunazosin | Small molecule | 3 mg | — |
| Subject | Doxazosin | Small molecule | 4 mg | — |
| Background | Valsartan | Small molecule | 80 mg | — |